Researchers partially restored the function of cone receptors in the retinas of children born completely blind by using gene therapy.
New gene therapy may help those with achromatopsia, or complete color blindness, to improve visual function. The treatment targets the CNGA3 gene, which is implicated in one-third of achromatopsia cases.
